Antigen-specific T cells fully conserve antitumour function following cryopreservation.
Jorge L Galeano Niño1,2, Rain Y Q Kwan1,2, Wolfgang Weninger1,2,3
1Immune Imaging Program, Centenary Institute of Cancer Medicine and Cell Biology, Newtown, New South Wales, Australia.
Immunology and Cell Biology
|January 13, 2016
Summary
Cryopreservation of T cells for immunotherapy fully preserves their function. This finding supports using cryopreserved T cells for cancer treatment, ensuring their effectiveness in fighting tumors.
Area of Science:
- Immunology
- Cellular Therapy
- Cancer Research
Background:
- Adoptive T-cell transfer immunotherapies are advancing for cancer treatment.
- Prolonged ex vivo T-cell culturing can diminish their therapeutic functionality.
Purpose of the Study:
- To investigate the impact of cryopreservation on ex vivo-expanded murine tumor-reactive CD8(+) T cells.
- To determine if cryopreservation affects T-cell differentiation, cytokine secretion, cytotoxic function, motility, and anti-tumor efficacy.
Main Methods:
- Comparison of cryopreserved and freshly isolated murine tumor-reactive CD8(+) T cells.
- Assessment of T-cell differentiation potential, cytokine profiles, cytotoxic activity, and 3D motility.
- Evaluation of tumor infiltration and rejection capacity in vivo.
Main Results:
- Cryopreservation maintained the differentiation potential of effector T cells.
- Pro-inflammatory cytokine secretion and cytotoxic functions remained intact post-cryopreservation.
- T-cell scanning motility, tumor infiltration, and rejection capabilities were not impaired by cryopreservation.
Conclusions:
- Cryopreservation is a viable strategy for preserving the functionality of ex vivo-expanded T cells for adoptive immunotherapy.
- This approach facilitates the storage and on-demand use of T cells, enhancing the logistical feasibility of cancer immunotherapeutic regimens.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Cytotoxic T Cells-mediated Immune Response
8.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.2K
Cell-mediated Immune Responses
86.1K
Overview
86.1K


